Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
BMC Systems Biology|January 13, 2012
Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studiesRotem Ben-Hamo, Sol EfroniPlos Computational Biology|November 27, 2013
MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanismsRotem Ben-Hamo, Sol EfroniGenome Medicine|November 30, 2011
Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progressionRotem Ben-Hamo, Sol EfroniBMC Systems Biology|February 12, 2011
The whole-organism heavy chain B cell repertoire from Zebrafish self-organizes into distinct network featuresRotem Ben-Hamo, Sol EfroniOncotarget|January 17, 2015
MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotypeRotem Ben-Hamo, Sol EfroniBioinformatics (Oxford, England)|May 10, 2014
PhenoNet: identification of key networks associated with disease phenotypeRotem Ben-Hamo, Moriah Gidoni, Sol EfroniImmunology|November 3, 2011
Rep-Seq: uncovering the immunological repertoire through next-generation sequencingJennifer Benichou, Rotem Ben-Hamo, Yoram Louzoun, et al.Oncotarget|April 2, 2016
hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elementsRotem Ben-Hamo, Alona Zilberberg, Helit Cohen, et al.Oncotarget|March 25, 2014
SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascadeRivki Cashman, Helit Cohen, Rotem Ben-Hamo, et al.Molecular Cancer Research : MCR|July 17, 2012
RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferationOrit Feldstein, Rotem Ben-Hamo, Dana Bashari, et al.Pageof 3